Status:
COMPLETED
A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Osteoarthritis, Hip
Musculoskeletal Diseases
Eligibility:
All Genders
35+ years
Phase:
PHASE3
Brief Summary
This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
Eligibility Criteria
Inclusion
- Patients with symptomatic osteoarthritis pain of hip
Exclusion
- Patients with current or prior conditions or treatment that would impede measurement of efficacy and safety
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00131326
Start Date
November 1 2003
End Date
April 1 2006
Last Update
July 31 2017
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Clinical Therapeutics
Birmingham, Alabama, United States, 35235
2
John Higginbotham, MD Sports Medicine
Huntsville, Alabama, United States, 35802
3
Affiliated Orthopedic Specialists
Scottsdale, Arizona, United States, 85260
4
Arkansas Orthopaedic Specialists
Little Rock, Arkansas, United States, 72205